UFP Technologies Inc (UFPT) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

Total Cash From Operating Activities Chart for UFP Technologies Inc

UFP Technologies Inc (UFPT) operating cash flow for FY2025 was USD 91.9M, a 38.0% change from FY2024. UFP Technologies Inc's operating cash flow grew from USD 1.2M in 1991 to USD 91.9M in 2025 (7558.8% over 34 years). Operating cash flow compound annual growth rate: 5-year CAGR of 29.7%, 10-year CAGR of 21.5%, 20-year CAGR of 25.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$2.29B
Implied Share Price
$295.78
Enterprise Value
$2.34B
Revenue (TTM)
$631.64M
EBITDA
$115.91M
Profit Margin
11.45%
Trailing P/E
31.94
Forward P/E
21.83
Price/Book (MRQ)
4.78
Price/Sales (TTM)
3.63
EV/EBITDA
20.13
EV/Revenue
3.70
Dividend Yield
—
Book Value
$59.70
Free Cash Flow (FY2025)
$78.98M
Free Cash Flow Yield
3.45%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.